Olmedipin Plus (Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide)

Olmesartan medoxomil, the active ingredient in Olmedipin Plus, is a combination antihypertensive presented as a tablet for oral use. It treats high blood pressure in adults, often when single‑agent therapy is insufficient.

GNH USA supplies Olmedipin Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmedipin Plus is a combination antihypertensive that addresses several pathways involved in blood pressure regulation. - Hypertension: helps achieve target blood pressure when monotherapy is inadequate. - Resistant hypertension: provides additional control through three complementary mechanisms. - Hypertensive patients with edema risk: amlodipine’s vasodilatory effect is balanced by the diuretic component.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Headache: mild to moderate discomfort. - Dizziness or light‑headedness: especially after the first doses. - Peripheral edema: swelling of ankles or feet. - Fatigue: general feeling of tiredness. - Increased urination: due to the diuretic component. - Electrolyte imbalance: mild changes in potassium or sodium levels.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing fainting. - Acute kidney injury: sudden decline in renal function. - Hyperkalemia: elevated potassium that may affect heart rhythm. - Angio‑edema: swelling of lips, tongue or airway. - Liver enzyme elevation: abnormal liver function tests. - Blood dyscrasias: rare blood cell abnormalities.

When prescribing Olmedipin Plus, clinicians should evaluate patient history and monitor relevant parameters. - Renal impairment: adjust therapy and monitor creatinine. - Hepatic disease: use with caution and observe liver function. - Electrolyte disturbances: check potassium and sodium levels regularly. - Pregnancy: avoid use; teratogenic risk is associated with angiotensin‑II blockers. - Concomitant diuretics: assess for additive electrolyte loss. - Store at ambient temperature: keep below 25°C, retain original packaging, protect from moisture.

Olmedipin Plus may interact with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Aliskiren: combined use with angiotensin‑II receptor blockers can increase risk of renal impairment. - Potassium‑rich supplements or potassium‑sparing diuretics: may cause dangerous hyper‑kalemia. - NSAIDs (high‑dose): can blunt antihypertensive effect and worsen renal function.

Moderate Interactions (Monitor Closely): - Lithium: may increase serum lithium levels. - CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): can raise amlodipine concentrations. - Antidiabetic agents: may enhance glucose‑lowering effect, requiring dose adjustment.